Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

THTX

Theratechnologies (THTX)

Theratechnologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:THTX
DateTimeSourceHeadlineSymbolCompany
12/19/20242:55PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
12/18/202412:30PMGlobeNewswire Inc.Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing EnvironmentNASDAQ:THTXTheratechnologies Inc
12/12/202410:58AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
12/10/20242:15PMGlobeNewswire Inc.Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLANASDAQ:THTXTheratechnologies Inc
12/09/20241:35PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
12/09/20246:30AMGlobeNewswire Inc.Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian CancerNASDAQ:THTXTheratechnologies Inc
12/05/20249:43AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
12/04/202410:44AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
12/04/20247:53AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
12/04/20246:30AMGlobeNewswire Inc.Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in CanadaNASDAQ:THTXTheratechnologies Inc
12/03/20243:30PMGlobeNewswire Inc.Theratechnologies Announces Resumed Production of EGRIFTA SV®NASDAQ:THTXTheratechnologies Inc
12/02/20249:20AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
12/02/20246:30AMGlobeNewswire Inc.Theratechnologies Secures up to $75 Million in New Credit Facilities with TD Bank and Investissement QuébecNASDAQ:THTXTheratechnologies Inc
11/26/202410:41AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
11/26/20246:30AMGlobeNewswire Inc.Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA ReviewNASDAQ:THTXTheratechnologies Inc
10/17/20241:00PMGlobeNewswire Inc.Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIVNASDAQ:THTXTheratechnologies Inc
10/17/20246:30AMGlobeNewswire Inc.Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug ResistanceNASDAQ:THTXTheratechnologies Inc
10/10/20247:36AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
10/10/20247:31AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
10/10/20246:30AMGlobeNewswire Inc.Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024NASDAQ:THTXTheratechnologies Inc
10/10/20245:48AMIH Market NewsU.S. Futures Fall Slightly as Investors Await CPI Data; Oil Prices RiseNASDAQ:THTXTheratechnologies Inc
10/09/20246:30AMGlobeNewswire Inc.Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIVNASDAQ:THTXTheratechnologies Inc
09/26/20246:30AMGlobeNewswire Inc.Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:THTXTheratechnologies Inc
09/25/202410:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
09/18/20249:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
09/17/20244:00PMGlobeNewswire Inc.Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025NASDAQ:THTXTheratechnologies Inc
09/09/20246:30AMGlobeNewswire Inc.Theratechnologies to Present at Upcoming Investor Conferences in SeptemberNASDAQ:THTXTheratechnologies Inc
07/10/20247:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
07/10/20247:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
07/10/20246:30AMGlobeNewswire Inc.Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024NASDAQ:THTXTheratechnologies Inc
 Showing the most relevant articles for your search:NASDAQ:THTX